This article is more than 5 years old. Information may no longer be current.
Top news of October: Sleep duration implications, statin intolerance and more
Click Here to Manage Email Alerts
Healio and Cardiology Today compiled a list of the most-viewed cardiology posts in October. This month, our readers were interested in the effect of sleep duration on CVD risk, the benefits of dog ownership for patients who have had a CVD event, the use of intermittent dosing to combat statin intolerance and much more.
Sleep duration may be predictive of cardiometabolic risk factors, cerebrovascular disease mortality
Sleep duration was found to be a significant predictor of cardiometabolic risk factors and cerebrovascular disease mortality as well as cancer mortality.
Dog ownership may improve outcomes, reduce mortality risk after CV events
Now people may have another reason to love their dogs even more: Dog ownership was linked to improved outcomes after a major CV event and with a lower risk for death in the long term, according to two studies published in Circulation: Cardiovascular Quality and Outcomes.
Statin intolerance can be fought with intermittent dosing
CHICAGO —Intermittent statin dosing is a treatment option that may have tremendous potential for addressing patients with statin intolerance who are trying to reduce LDL, according to a speaker at the Cardiometabolic Health Congress.
Intervention improves adherence to Mediterranean diet
An intervention promoting an energy-reduced Mediterranean diet and physical activity was linked with better adherence to the Mediterranean diet at 1 year compared with the traditional Mediterranean diet in individuals with metabolic syndrome, according to interim results from the PREDIMED-Plus study.
LEGEND-HTN: Thiazide, thiazide-like diuretics superior to ACE inhibitors
Drug classes used as monotherapy for hypertension were shown to be comparable, although thiazide or thiazide-like diuretics were superior to ACE inhibitors, according to results from the LEGEND-HTN study published in The Lancet.
High-fiber diet improves CV risk factors in hypertension, diabetes
A high-fiber, low-glycemia index diet showed a strong protective role against CVD and CV risk reduction in patients with hypertension and type 2 diabetes, according to findings presented at the ACC Middle East Conference.
Children exposed to secondhand smoke at home at greater risk for AF
Children who were exposed to secondhand smoke by a parent not only had a significantly higher risk for developing atrial fibrillation but also were more likely to begin smoking themselves.
Top 10 takeaways from lipid management guidelines
CHICAGO — The 2018 Guideline on the Management of Blood Cholesterol, published by the American College of Cardiology and the American Heart Association in collaboration with other societies, offered a number of pointers for clinicians to diagnose, treat and manage patients with elevated cholesterol.
Catheter ablation for AF: Debate continues over benefit
The debate on the use of catheter ablation in patients with atrial fibrillation has intensified among cardiologists after results of the anticipated CABANA trial demonstrated that the procedure conferred better outcomes in patients with AF compared with medical therapy in per-protocol and on-treatment analyses, but not in an intention-to-treat analysis.
Maintained weight loss improves cardiometabolic risk factors in diabetes
Among patients with diabetes who lost weight, those who maintained their weight loss significantly improved their cardiometabolic risk factors compared with those who regained weight, according to a study published in the Journal of the American Heart Association.